All Insights
Showing 37 - 48 of 239
Regulatory Outlook
Products | UK Regulatory Outlook February 2023
Medical Technology Strategy | UK to introduce regulatory framework for point of care manufacturing | Commission launches call for evidence
Brexit
The UK Retained EU Law Bill: legislative havoc or promised post-Brexit deregulation?
As the House of Lords begins its second reading of the controversial bill, we look at what it does, what
Regulatory Outlook
Food law | UK Regulatory Outlook January 2023
New novel foods? | Genetically modified crops? | New timescales for HFSS products
Knowledge Notes
UK business law predictions for 2023
As the new year unfolds, we look ahead at what legal developments businesses can expect
The Built Environment
A look ahead for UK real estate in 2023
The new year will be a busy one – including the implementation of new regimes for overseas ownership of UK
Life Sciences and Healthcare
Regulatory Horizons Council makes recommendations to UK government for the regulation of AI as a medical device
'Urgent need to get the regulation right' says RHC report which recommends an increase in regulatory capacity and capability to
Regulatory Outlook
Data protection | UK Regulatory Outlook November 2022
ICO publishes updated guidance on international data transfer requirements | UK government finalises South Korea data adequacy decision | Deadline
Regulatory Outlook
Products | UK Regulatory Outlook November 2022
Government further delays use of UK product safety marking | UK-wide packaging regulations expected to enter into force in late
Intellectual property
General Court finds UK evidence not admissible post-Brexit in EUIPO proceedings
Judgment disagrees with earlier decisions and rejects UK evidence despite pre-Brexit filing date of contested EU mark
Life Sciences and Healthcare
MHRA moves to assuage medical device manufacturers over UK's post-Brexit plans
Businesses will have more time to prepare for the new UKCA marking regime and comment on draft medical device regulations
Life Sciences and Healthcare
The UK medical devices regime and the impact of the Northern Ireland Protocol
Life Sciences analysis: Peter Rudd-Clarke, partner, and Anna Lundy, associate director, at Osborne Clarke discuss how the medical device industry
IT and data
UK government outlines data protection reform proposals following consultation
What are the main areas of reform for the UK's data protection regime and how will they affect business?
